Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

global phase

4 posts
NNovo Nordisk
Novo Nordisk Confronts Hims Over Wegovy Pill Copies And GLP 1 Future
Read More

Novo Nordisk Triple Agonist Progress Spurs Questions On Valuation Gap

  • 2026-04-02
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
NNovo Nordisk
Novo Nordisk Confronts Hims Over Wegovy Pill Copies And GLP 1 Future
Read More

Novo Nordisk Weighs UBT251 Triple Agonist Against Semaglutide In Next Trials

  • 2026-03-26
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
NNovo Nordisk
Novo Nordisk initiates 2026 share repurchase programme
Read More

Triple agonist UBT251 showed a mean HbA1c reduction of up to 2.16% after 24 weeks in phase 2 trial in Chinese patients with type 2 diabetes

  • 2026-03-25
Novo Nordisk A/S UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G),…
NNovo Nordisk
Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
Read More

Triple agonist UBT251 showed a mean HbA1c reduction of up to 2.16% after 24 weeks in phase 2 trial in Chinese patients with type 2 diabetes

  • 2026-03-25
Novo Nordisk A/S UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G),…
Denmark
www.europesays.com